![Claude Gingras](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Claude Gingras
Former positions of Claude Gingras
Companies | Position | Start | End |
---|---|---|---|
Alpha Biologics Ltd.
![]() Alpha Biologics Ltd. Pharmaceuticals: MajorHealth Technology Alpha Biologics is a Contract Manufacturer of Biologics drugs for use in pre-clinical, Phase1 and 2 clinical trials, anywhere in the World. The life sciences industry is experiencing spiralling drug development costs that are making it increasingly difficult for biotech and pharma companies to survive, let alone prosper. Alpha Biologics has been established to address this issue by providing its clients with the opportunity to take their biologic drugs through the early clinical trial phases at a cost is easily justified. This avoids the abandonment of potential blockbuster drug programmes based simply on cost before it has been possible to demonstrate safety and early efficacy. It specialises in the production of mammalian cell secreted protein drugs, and it provide all of the necessary services required to develop and produce its clients' drugs in full compliance with U.S. and European cGMP guidelines. Its manufacturing base in Malaysia brings significant cost advantages to its customers due to the lower overhead costs compared with Europe or the U.S., whilst maintaining the highest standards of compliance. Its core team has extensive experience of designing, building and operating cGMP compliant facilities for biologic drugs in the U.S. and Europe. This core team has been strengthened by internationally trained and experienced staff from the World-wide biologics industry and academia. Its goal is to deliver drugs on time for clinical trials at a price that is affordable, thereby enabling its clients' to maintain strong drug development pipelines and realise maximum value from the investments in research and development. | Director/Board Member | - | 23/07/2012 |
VIROPRO INC. | Director/Board Member | 05/01/2011 | 20/07/2012 |
Compliance Officer | 15/03/2008 | 20/07/2012 | |
Director of Finance/CFO | 05/01/2011 | 20/07/2012 | |
Public Communications Contact | 05/01/2011 | - | |
Corporate Secretary | 15/03/2008 | 20/07/2012 |
Training of Claude Gingras
Université Laval | Undergraduate Degree |
Statistics
International
Canada | 2 |
United States | 2 |
United Kingdom | 2 |
Operational
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Compliance Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VIROPRO INC. | Health Technology |
Private companies | 1 |
---|---|
Alpha Biologics Ltd.
![]() Alpha Biologics Ltd. Pharmaceuticals: MajorHealth Technology Alpha Biologics is a Contract Manufacturer of Biologics drugs for use in pre-clinical, Phase1 and 2 clinical trials, anywhere in the World. The life sciences industry is experiencing spiralling drug development costs that are making it increasingly difficult for biotech and pharma companies to survive, let alone prosper. Alpha Biologics has been established to address this issue by providing its clients with the opportunity to take their biologic drugs through the early clinical trial phases at a cost is easily justified. This avoids the abandonment of potential blockbuster drug programmes based simply on cost before it has been possible to demonstrate safety and early efficacy. It specialises in the production of mammalian cell secreted protein drugs, and it provide all of the necessary services required to develop and produce its clients' drugs in full compliance with U.S. and European cGMP guidelines. Its manufacturing base in Malaysia brings significant cost advantages to its customers due to the lower overhead costs compared with Europe or the U.S., whilst maintaining the highest standards of compliance. Its core team has extensive experience of designing, building and operating cGMP compliant facilities for biologic drugs in the U.S. and Europe. This core team has been strengthened by internationally trained and experienced staff from the World-wide biologics industry and academia. Its goal is to deliver drugs on time for clinical trials at a price that is affordable, thereby enabling its clients' to maintain strong drug development pipelines and realise maximum value from the investments in research and development. | Health Technology |
- Stock Market
- Insiders
- Claude Gingras
- Experience